Dr. Patnaik on Challenges With Sequencing Therapies in mCRPC
August 11th 2016Akash Patnaik, MD, PhD, assistant professor of Medicine at the University of Chicago Medicine, discusses the challenges with sequencing available agents for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
Read More